Skip to main content
Signal8

Domicilium Real Estate Fund III LP

SEC insider (Form 3/4/5 filer). CIK 0001945896. 10% Owner at Eloxx Pharmaceuticals, Inc. (ELOX). 3 reported Form 4/5 transactions since Sep 2024; latest on Jun 10, 2026. Located in SOUTHLAKE, TX.

Companies Domicilium Real Estate Fund III LP has filed insider reports for

  • Eloxx Pharmaceuticals, Inc. (ELOX): 10% Owner
Domicilium Real Estate Fund III LP profile photo

Domicilium Real Estate Fund III LP

CIK: 0001945896

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)0 (0.0%)

Compensation grants

Other (G, F, J, C, D, …)3 (100.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Eloxx Pharmaceuticals, Inc. logo
ELOX

Eloxx Pharmaceuticals, Inc.

10% Owner

Discretionary Trading P&L

Holdings

Transaction History (3 total)

  • Eloxx Pharmaceuticals, Inc. logo
    ELOX

    Eloxx Pharmaceuticals, Inc.

    Jun 10, 2026
    Other
    Indirect
    238.4K shares-
  • Eloxx Pharmaceuticals, Inc. logo
    ELOX

    Eloxx Pharmaceuticals, Inc.

    Jun 10, 2026
    Other
    Indirect
    361.6K shares-
  • Eloxx Pharmaceuticals, Inc. logo
    ELOX

    Eloxx Pharmaceuticals, Inc.

    May 27, 2026
    Other
    Direct
    113.6K shares-

1-3 of 3